An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for ...

A new study published in the Journal of American Medical Association showed that nirsevimab offers protection against a ...

Nirsevimab-resistant respiratory syncytial virus variants remain rare, but continued molecular surveillance is crucial. Read now.

Immunisation with nirsevimab reduced bronchiolitis-related hospitalisations among infants younger than 3 months who visited the emergency department (ED), according to a new study. Nirsevimab also ...

Fresno County health officials have confirmed the first pediatric deaths linked to flu and RSV this season, urging ...

The incident occurred months after health authorities discovered the GP’s clinic had incorrectly stored vaccines, potentially ...

March 6, 2025 — Carolyn Figurelle was in Las Vegas getting ready for her sister-in-law’s wedding when her 6-month-old son’s breathing became shallow. Carolyn, in the emergency room in ...

The medication, called nirsevimab, is given via injection to infants under eight months old and uses lab-made antibodies to ...

Vermont has the second lowest state fatality rate in the US (146.4 per 100K; Hawaii 112.8/100K). Mississippi (463.1/100K) and Oklahoma (459.1/100K) have the highest rates. The US average is 306.7/100K ...